Back to mobile site

RBC Capital Starts Abbvie (ABBV) at Outperform

February 24, 2026 4:07 PM EST Send to a Friend
RBC Capital analyst Trung Huynh initiates coverage on Abbvie (NYSE: ABBV) with a Outperform rating and a price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login